The National Asthma Council Australia has been advised that salbutamol inhalation solution 2.5mg/2.5mL (Ventolin Nebules) is now available once again, following the supply shortage that was anticipated until mid-2024.
The shortage did not apply to salbutamol inhalation solution 5mg/2.5mL (Ventolin Nebules). Salbutamol Cipla 2.5mg/2.5mL brand remains unavailable.
Salbutamol nebules are indicated for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease (COPD), and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.
The Pharmaceutical Benefits Schedule (PBS) restricts the prescription of salbutamol nebules to patients with asthma and COPD unable to use an oral pressurised inhalation device via a spacer.
View the March 2024 update with recommendations and references.
